Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Elite Pharmaceuticals Inc.

www.elitepharma.com

Latest From Elite Pharmaceuticals Inc.

Keeping Track: FDA Rejects Mealtime Insulin, Antihistamine; Misses Goal For Another Opioid

The latest drug development news and highlights from our FDA Performance Tracker.

Approvals Drug Review

Deal Watch: Amgen BiTEs Back Micromet-Developed Boehringer Antibody

Cancer immunotherapy biotech Leap, backed by HealthCare Ventures and Lilly, reverse-merges with Israel's Macrocure. Elite and SunGen will partner to develop generic versions of four drugs that posted $3bn in aggregate sales over a recent 12-month stretch.

Deals Business Strategies

Keeping Track: Approval Elusive For Biosimilar Neulasta; Valeant Gets A Nod And A No From FDA; Submissions From Amgen, Puma, Bristol

The latest drug development news and highlights from our FDA Performance Tracker

United States BioPharmaceutical

PIPELINE WATCH: Eight Approvals, Seven Filings And Three Launches

This week's Pipeline Watch, a snapshot of all the late-stage R&D and regulatory events in the pharma and biotech industries, is now available to view.

Research & Development Pipeline Watch
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
    • Generic Drugs
    • OTC, Consumer
  • Therapeutic Areas
  • Cardiovascular
  • Gastrointestinal
  • Immune Disorders
  • Musculoskeletal & Connective Tissue Disorders
  • Neurology, Nervous System
  • Alias(es)
  • Elite Laboratories Inc.
  • Prologica International Inc.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Elite Pharmaceuticals Inc.
  • Senior Management
  • Nasrat Hakim, Pres. & CEO
    Carter J Ward, CFO
    Chris Dick, Head, Dev.
    Doug Plassche, EVP, Operations
  • Contact Info
  • Elite Pharmaceuticals Inc.
    Phone: (201) 750-2646
    165 Ludlow Ave.
    Northvale, NJ 07647
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register